Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-23-067072)

Filing Details

Accession Number:: 0000950170-23-067072
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-11-30 17:00:07
Reporting Period:: 2023-11-30

Accepted Time:: 2023-11-30 17:00:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1833214	Sab Biotherapeutics Inc.	SABS	Biological Products, (No Disgnostic Substances) (2836)	853899721

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1998530	Michael King	2100 E 54Th Street North Sioux Falls SD 57104	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-11-30	5,000	$0.90	5,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents 5,000 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.